Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-009119
Filing Date
2022-03-11
Accepted
2022-03-11 16:05:30
Documents
9
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A ny20001664x1_pre14a.htm PRE 14A 1346518
2 logo_prothena.jpg GRAPHIC 23464
3 ny20001664x1_diversitymatrix.jpg GRAPHIC 228190
4 ny20001664x1_dosanddonts.jpg GRAPHIC 479245
5 ny20001664x1_pc1.jpg GRAPHIC 806269
6 ny20001664x1_pc2.jpg GRAPHIC 798275
7 ny20001664x1_piechart1.jpg GRAPHIC 125704
8 ny20001664x1_skills.jpg GRAPHIC 681406
9 sig_yvonnemtchrakian.jpg GRAPHIC 19458
  Complete submission text file 0001140361-22-009119.txt   5700925
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35676 | Film No.: 22733149
SIC: 2834 Pharmaceutical Preparations